OrbiMed’s Amarin Corp AMRN Stock Holding History

OrbiMed’s Portfolio AMRN Stock Details AMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12,480	Closed	-$5.35M	–	145
2019 Q4	$5.35M	Buy	12,480 +1,425	+13%	+$541K	0.08%	102
2019 Q3	$3.35M	Sell	11,055 -24,825	-69%	-$8.66M	0.06%	102
2019 Q2	$13.9M	Buy	35,880 +12,500	+53%	+$4.58M	0.22%	83
2019 Q1	$9.71M	Buy	23,380 +19,330	+477%	+$6.97M	0.15%	92
2018 Q4	$1.1M	Buy	+4,050	New	+$1.48M	0.02%	120
2017 Q3	–	Sell	-10,243	Closed	-$826K	–	144
2017 Q2	$826K	Sell	10,243 -7,257	-41%	-$451K	0.01%	132
2017 Q1	$1.12M	Hold	17,500	–	–	0.01%	127
2016 Q4	$1.08M	Hold	17,500	–	–	0.01%	123
2016 Q3	$1.12M	Hold	17,500	–	–	0.01%	130
2016 Q2	$756K	Hold	17,500	–	–	0.01%	130
2016 Q1	$536K	Hold	17,500	–	–	0.01%	141
2015 Q4	$662K	Hold	17,500	–	–	0.01%	126
2015 Q3	$676K	Hold	17,500	–	–	0.01%	129
2015 Q2	$861K	Hold	17,500	–	–	0.01%	135
2015 Q1	$819K	Sell	17,500 -2,500	-13%	-$76.4K	0.01%	133
2014 Q4	$392K	Hold	20,000	–	–	﹤0.01%	130
2014 Q3	$436K	Hold	20,000	–	–	﹤0.01%	129
2014 Q2	$704K	Hold	20,000	–	–	0.01%	128
2014 Q1	$724K	Sell	20,000 -10,000	-33%	-$372K	0.01%	138
2013 Q4	$1.18M	Hold	30,000	–	–	0.02%	112
2013 Q3	$3.79M	Hold	30,000	–	–	0.07%	108
2013 Q2	$3.48M	Buy	+30,000	New	+$4.14M	0.07%	112

Other funds holding AMRN

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

OrbiMed's AMRN Position: Q1 2020 in Review

OrbiMed sold out of Amarin Corp (AMRN) in Q1 2020, closing a stake of 12,480 shares — an estimated $5.35M sold.

OrbiMed first reported a position in AMRN in Q2 2013 and held it in 22 quarters. The position peaked at $13.9M in Q2 2019. 306 funds tracked by Wall St. Rank hold AMRN as of Q1 2020.

OrbiMed reported no remaining Amarin Corp position as of Q1 2020 after selling out during the quarter.
OrbiMed sold 12,480 Amarin Corp shares in Q1 2020, an estimated $5.35M.
OrbiMed first reported a position in Amarin Corp in Q2 2013 and held it in 22 quarters.
OrbiMed's Amarin Corp position peaked at $13.9M in Q2 2019.
306 funds tracked by Wall St. Rank held Amarin Corp as of Q1 2020.

Based on OrbiMed's 13F filing for Q1 2020, filed 15 May 2020.